Amyris (AMRS) Executes Definitive Agreements with Nutraceuticals Partner; Includes Strategic Investment, Credit Facility
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Amyris Executes Definitive Collaboration Agreements with Leading Global Nutraceuticals Partner
October 26, 2016 9:47 AM EDTEMERYVILLE, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq: AMRS), the industrial bioscience company has executed definitive agreements for its strategic partnership and financing with a global nutraceuticals market leader as previously described on September 30, 2016. These agreements include the expansion of a new nutraceutical market that is expected to represent $40-$50 million of annual revenue once developed and scaled, a related strategic investment, and an unsecured credit facility of $25 million with a five-year maturity.
We are very pleased with the significant traction we are experiencing in the first market we... More
